KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Operating Leases (2019 - 2025)

Labcorp Holdings' Operating Leases history spans 7 years, with the latest figure at $692.0 million for Q3 2025.

  • For Q3 2025, Operating Leases fell 1.33% year-over-year to $692.0 million; the TTM value through Sep 2025 reached $692.0 million, down 1.33%, while the annual FY2024 figure was $676.3 million, 4.22% up from the prior year.
  • Operating Leases for Q3 2025 was $692.0 million at Labcorp Holdings, down from $713.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $713.1 million in Q2 2025 and bottomed at $623.5 million in Q2 2023.
  • The 5-year median for Operating Leases is $657.8 million (2021), against an average of $659.9 million.
  • The largest annual shift saw Operating Leases dropped 6.86% in 2023 before it rose 11.5% in 2025.
  • A 5-year view of Operating Leases shows it stood at $642.5 million in 2021, then grew by 1.62% to $652.9 million in 2022, then decreased by 0.61% to $648.9 million in 2023, then rose by 4.22% to $676.3 million in 2024, then increased by 2.32% to $692.0 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Operating Leases are $692.0 million (Q3 2025), $713.1 million (Q2 2025), and $696.4 million (Q1 2025).